These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 28423611)

  • 1. The stem cell/cancer stem cell marker ALDH1A3 regulates the expression of the survival factor tissue transglutaminase, in mesenchymal glioma stem cells.
    Sullivan KE; Rojas K; Cerione RA; Nakano I; Wilson KF
    Oncotarget; 2017 Apr; 8(14):22325-22343. PubMed ID: 28423611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesenchymal glioma stem cells are maintained by activated glycolytic metabolism involving aldehyde dehydrogenase 1A3.
    Mao P; Joshi K; Li J; Kim SH; Li P; Santana-Santos L; Luthra S; Chandran UR; Benos PV; Smith L; Wang M; Hu B; Cheng SY; Sobol RW; Nakano I
    Proc Natl Acad Sci U S A; 2013 May; 110(21):8644-9. PubMed ID: 23650391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ALDH1A3: A Marker of Mesenchymal Phenotype in Gliomas Associated with Cell Invasion.
    Zhang W; Liu Y; Hu H; Huang H; Bao Z; Yang P; Wang Y; You G; Yan W; Jiang T; Wang J; Zhang W
    PLoS One; 2015; 10(11):e0142856. PubMed ID: 26575197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ALDH1A3 in CSCs.
    Sullivan KE; Cerione RA; Wilson KF
    Aging (Albany NY); 2017 May; 9(5):1351-1352. PubMed ID: 28476022
    [No Abstract]   [Full Text] [Related]  

  • 5. A novel drug conjugate, NEO212, targeting proneural and mesenchymal subtypes of patient-derived glioma cancer stem cells.
    Jhaveri N; Agasse F; Armstrong D; Peng L; Commins D; Wang W; Rosenstein-Sisson R; Vaikari VP; Santiago SV; Santos T; Chen L; Schönthal AH; Chen TC; Hofman FM
    Cancer Lett; 2016 Feb; 371(2):240-50. PubMed ID: 26683773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. USP9X deubiquitinates ALDH1A3 and maintains mesenchymal identity in glioblastoma stem cells.
    Chen Z; Wang HW; Wang S; Fan L; Feng S; Cai X; Peng C; Wu X; Lu J; Chen D; Chen Y; Wu W; Lu D; Liu N; You Y; Wang H
    J Clin Invest; 2019 Apr; 129(5):2043-2055. PubMed ID: 30958800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FOXD1-ALDH1A3 Signaling Is a Determinant for the Self-Renewal and Tumorigenicity of Mesenchymal Glioma Stem Cells.
    Cheng P; Wang J; Waghmare I; Sartini S; Coviello V; Zhang Z; Kim SH; Mohyeldin A; Pavlyukov MS; Minata M; Valentim CL; Chhipa RR; Bhat KP; Dasgupta B; La Motta C; Kango-Singh M; Nakano I
    Cancer Res; 2016 Dec; 76(24):7219-7230. PubMed ID: 27569208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression profiling distinguishes proneural glioma stem cells from mesenchymal glioma stem cells.
    Chandran UR; Luthra S; Santana-Santos L; Mao P; Kim SH; Minata M; Li J; Benos PV; DeWang M; Hu B; Cheng SY; Nakano I; Sobol RW
    Genom Data; 2015 Sep; 5():333-336. PubMed ID: 26251826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stem cell signature in glioblastoma: therapeutic development for a moving target.
    Nakano I
    J Neurosurg; 2015 Feb; 122(2):324-30. PubMed ID: 25397368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A specific inhibitor of ALDH1A3 regulates retinoic acid biosynthesis in glioma stem cells.
    Li J; Garavaglia S; Ye Z; Moretti A; Belyaeva OV; Beiser A; Ibrahim M; Wilk A; McClellan S; Klyuyeva AV; Goggans KR; Kedishvili NY; Salter EA; Wierzbicki A; Migaud ME; Mullett SJ; Yates NA; Camacho CJ; Rizzi M; Sobol RW
    Commun Biol; 2021 Dec; 4(1):1420. PubMed ID: 34934174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aldehyde dehydrogenase 1A3 (ALDH1A3) is regulated by autophagy in human glioblastoma cells.
    Wu W; Schecker J; Würstle S; Schneider F; Schönfelder M; Schlegel J
    Cancer Lett; 2018 Mar; 417():112-123. PubMed ID: 29306018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transglutaminase 2 Inhibition Reverses Mesenchymal Transdifferentiation of Glioma Stem Cells by Regulating C/EBPβ Signaling.
    Yin J; Oh YT; Kim JY; Kim SS; Choi E; Kim TH; Hong JH; Chang N; Cho HJ; Sa JK; Kim JC; Kwon HJ; Park S; Lin W; Nakano I; Gwak HS; Yoo H; Lee SH; Lee J; Kim JH; Kim SY; Nam DH; Park MJ; Park JB
    Cancer Res; 2017 Sep; 77(18):4973-4984. PubMed ID: 28754668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell surface GRP78 regulates BACE2 via lysosome-dependent manner to maintain mesenchymal phenotype of glioma stem cells.
    Chen Z; Wang H; Zhang Z; Xu J; Qi Y; Xue H; Gao Z; Zhao R; Wang S; Zhang S; Qiu W; Guo X; Li G
    J Exp Clin Cancer Res; 2021 Jan; 40(1):20. PubMed ID: 33413577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High expression of ALDH1A3 might independently influence poor progression-free and overall survival in patients with glioma via maintaining glucose uptake and lactate production.
    Ni W; Xia Y; Luo L; Wen F; Hu D; Bi Y; Qi J
    Cell Biol Int; 2020 Feb; 44(2):569-582. PubMed ID: 31642564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deubiquitinating ALDH1A3 key to maintaining the culprit of aggressive brain cancer.
    Wakimoto H
    J Clin Invest; 2019 Apr; 129(5):1833-1835. PubMed ID: 30958802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ALDH1A3, a metabolic target for cancer diagnosis and therapy.
    Duan JJ; Cai J; Guo YF; Bian XW; Yu SC
    Int J Cancer; 2016 Sep; 139(5):965-75. PubMed ID: 26991532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Citral reduces breast tumor growth by inhibiting the cancer stem cell marker ALDH1A3.
    Thomas ML; de Antueno R; Coyle KM; Sultan M; Cruickshank BM; Giacomantonio MA; Giacomantonio CA; Duncan R; Marcato P
    Mol Oncol; 2016 Nov; 10(9):1485-1496. PubMed ID: 27592281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aldehyde dehydrogenase 1A3 influences breast cancer progression via differential retinoic acid signaling.
    Marcato P; Dean CA; Liu RZ; Coyle KM; Bydoun M; Wallace M; Clements D; Turner C; Mathenge EG; Gujar SA; Giacomantonio CA; Mackey JR; Godbout R; Lee PW
    Mol Oncol; 2015 Jan; 9(1):17-31. PubMed ID: 25106087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TGM2 inhibition attenuates ID1 expression in CD44-high glioma-initiating cells.
    Fu J; Yang QY; Sai K; Chen FR; Pang JC; Ng HK; Kwan AL; Chen ZP
    Neuro Oncol; 2013 Oct; 15(10):1353-65. PubMed ID: 23877317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-α/β enhances temozolomide activity against MGMT-positive glioma stem-like cells.
    Shen D; Guo CC; Wang J; Qiu ZK; Sai K; Yang QY; Chen YS; Chen FR; Wang J; Panasci L; Chen ZP
    Oncol Rep; 2015 Nov; 34(5):2715-21. PubMed ID: 26329778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.